Yujia Li

2.6k total citations · 1 hit paper
95 papers, 1.8k citations indexed

About

Yujia Li is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Yujia Li has authored 95 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 24 papers in Immunology and 23 papers in Epidemiology. Recurrent topics in Yujia Li's work include interferon and immune responses (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Yujia Li is often cited by papers focused on interferon and immune responses (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Yujia Li collaborates with scholars based in China, United States and Canada. Yujia Li's co-authors include Jiangjuan Shao, Zili Zhang, Shizhong Zheng, Shanzhong Tan, Mei Guo, Anping Chen, Min Shen, Desong Kong, Shilin Li and Feng Zhang and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yujia Li

89 papers receiving 1.8k citations

Hit Papers

RNA-binding protein ZFP36/TTP protects against ferroptosi... 2019 2026 2021 2023 2019 100 200 300

Peers

Yujia Li
Ming Shan China
Donna Beer–Stolz United States
Xu D China
Guoli Li China
Yujia Li
Citations per year, relative to Yujia Li Yujia Li (= 1×) peers Xiaojun Lu

Countries citing papers authored by Yujia Li

Since Specialization
Citations

This map shows the geographic impact of Yujia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Li more than expected).

Fields of papers citing papers by Yujia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Li. The network helps show where Yujia Li may publish in the future.

Co-authorship network of co-authors of Yujia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yujia Li. A scholar is included among the top collaborators of Yujia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujia Li. Yujia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Mengran, et al.. (2025). Artemether relieves liver fibrosis by triggering ferroptosis in hepatic stellate cells via DHHC12-mediated S-palmitoylation of the BECN1 protein. Free Radical Biology and Medicine. 231. 120–135. 5 indexed citations
2.
Li, Yujia, et al.. (2025). HDAC4 regulates apoptosis in Acan‐ Cre ERT2 ; HDAC4 d /d mice with osteoarthritis by downregulating ATF4. FEBS Open Bio. 15(5). 726–737. 2 indexed citations
3.
Yang, Qi, Mengmeng Cui, Jiaxin Wang, et al.. (2025). Circulating mitochondrial DNA promotes M2 polarization of tumor associated macrophages and HCC resistance to sorafenib. Cell Death and Disease. 16(1). 153–153. 9 indexed citations
4.
5.
Wang, Yijin, Xinwei Wang, Bin Fan, et al.. (2024). Autophagy‐related protein 5 (ATG5) interacts with bone marrow stromal cell antigen 2 (BST2) to stimulate HBV replication through antagonizing the antiviral activity of BST2. Journal of Medical Virology. 96(5). e29659–e29659. 2 indexed citations
7.
Li, Yujia & Weihai Ying. (2023). Methylene blue reduces the serum levels of interleukin-6 and inhibits STAT3 activation in the brain and the skin of lipopolysaccharide-administered mice. Frontiers in Immunology. 14. 1181932–1181932. 4 indexed citations
8.
Duan, Xiaoqiong, Yujia Li, Min Xu, et al.. (2023). Vaccination increased host antiviral gene expression and reduced COVID-19 severity during the Omicron variant outbreak in Fuyang City, China. International Immunopharmacology. 120. 110333–110333. 1 indexed citations
9.
Wang, Yingqian, Min Shen, Yujia Li, et al.. (2023). COVID‐19‐associated liver injury: Adding fuel to the flame. Cell Biochemistry and Function. 41(8). 1076–1092. 1 indexed citations
10.
Wang, Yingqian, Yujia Li, Min Shen, et al.. (2023). Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis. Journal of Clinical and Translational Hepatology. 12(1). 36–51. 10 indexed citations
11.
Xu, Xuefen, Siwei Xia, Li Chen, et al.. (2023). Induction of DNMT1-dependent demethylation of SHP-1 by the natural flavonoid compound Baicalein overcame Imatinib-resistance in CML CD34+ cells. Cell Communication and Signaling. 21(1). 47–47. 1 indexed citations
12.
Li, Xiaofang, Wei Zhang, Wenxuan Liu, et al.. (2023). ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance. Free Radical Biology and Medicine. 199. 126–140. 13 indexed citations
13.
Li, Yujia, Qi Yang, Hui Chen, et al.. (2022). TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway. Oncogene. 41(30). 3735–3746. 42 indexed citations
14.
Feng, Rilu, Shanshan Wang, Hui Liu, et al.. (2022). FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression. Gut. 72(3). 549–559. 16 indexed citations
15.
Schnabl, Bernd, Gavin E. Arteel, Felix Stickel, et al.. (2022). Liver specific, systemic and genetic contributors to alcohol-related liver disease progression. Zeitschrift für Gastroenterologie. 60(1). 36–44. 2 indexed citations
16.
Ren, Kai, Honggang Sun, Shilin Li, et al.. (2021). IRF2 inhibits ZIKV replication by promoting FAM111A expression to enhance the host restriction effect of RFC3. Virology Journal. 18(1). 256–256. 9 indexed citations
17.
Li, Yujia, et al.. (2020). Easily misdiagnosed intramuscular hemangioma: a case report. Journal of International Medical Research. 48(12). 1220766449–1220766449. 3 indexed citations
18.
Li, Yujia, Bo Qin, Liang Lin, et al.. (2019). The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity. Mediators of Inflammation. 2019. 1–12. 6 indexed citations
20.
Li, Shilin, et al.. (2013). The Role of MicroRNA in Hepatitis C Virus Replication. Journal of Clinical and Translational Hepatology. 1(2). 125–30.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026